Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?

Authors Kjeldgaard P, Dahl R, Løkke A, Ulrik CS

Received 18 October 2014

Accepted for publication 6 December 2014

Published 23 February 2015 Volume 2015:10(1) Pages 407—414

DOI https://doi.org/10.2147/COPD.S76047

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Dr Richard Russell

Peter Kjeldgaard,1 Ronald Dahl,2 Anders Løkke,3 Charlotte Suppli Ulrik1,4

1Department of Pulmonary Medicine, Hvidovre Hospital, Hvidovre; 2Allergy Centre, Odense University Hospital, Odense, 3Department of Pulmonary Medicine, Århus Sygehus, Aarhus C; 4University of Copenhagen, Copenhagen, Denmark

Background: Underdiagnosis of chronic obstructive pulmonary disease (COPD) is widespread. Early detection of COPD may improve the outcome by timely smoking cessation, a change in lifestyle, and treatment with an inhaled bronchodilator (BD). The objective of this study was to evaluate the diagnostic role of BD reversibility testing in early COPD case finding.
Methods: General practitioners (n=241) consecutively recruited subjects aged ≥35 years with relevant exposure (history of smoking, and/or occupational exposure) and at least one respiratory symptom. Information on age, smoking status, body mass index, dyspnea score (Medical Research Council scale), and spirometry was obtained. Individuals with airway obstruction (forced expiratory volume in one second [FEV1]/forced vital capacity [FVC] <0.70) underwent a BD test with an inhaled β2 agonist, which was considered positive if ΔFEV1 was >0.20 L and >12%. Asthma and COPD were, respectively, defined as an FEV1 increase >0.50 L and a post-BD FEV1/FVC <0.70.
Results: In total, 4,049 subjects (51% male) were included (mean age 58 years, body mass index 27, 32 pack-years of smoking). A significant BD response was found in 143 (15%) of the 937 subjects (23%) with airway obstruction at screening spirometry. In 59% of these subjects, the post-BD FEV1/FVC remained <0.70. In 24% of the subjects with pre-BD airway obstruction, the post-BD FEV1/FVC ratio was within the reference range. In subjects with confirmed COPD, the mean increase in FEV1 following BD was 0.11 L±0.10 L. The subjects with COPD and a significant BD response were characterized by a higher prevalence of dyspnea (72% versus 57%, P=0.02) but less cough (55% versus 75%, P=0.001) when compared with COPD subjects without BD reversibility.
Conclusion: Administration of a BD in COPD case finding is important in order to determine the post-BD FEV1/FVC ratio. Exclusion of subjects with a significant BD response may result in underdiagnosis of COPD, and we question the need for the BD reversibility test in the diagnostic screening algorithm in early COPD case finding.

Keywords: chronic obstructive pulmonary disease, screening, reversibility, diagnosis, spirometry


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Do telemedical interventions improve quality of life in patients with COPD? A systematic review

Gregersen TL, Green A, Frausing E, Ringbæk T, Brøndum E, Suppli Ulrik C

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:809-822

Published Date: 21 April 2016

Beta-blockers: friend or foe in asthma?

Arboe B, Ulrik CS

International Journal of General Medicine 2013, 6:549-555

Published Date: 8 July 2013

Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries

Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:571-576

Published Date: 14 September 2012

Asthma and obesity: does weight loss improve asthma control? a systematic review

Juel CTB, Ali Z, Nilas L, Ulrik CS

Journal of Asthma and Allergy 2012, 5:21-26

Published Date: 7 June 2012

Early detection of COPD in general practice

Charlotte Suppli Ulrik, Anders Løkke, Ronald Dahl, et al

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:123-127

Published Date: 28 January 2011

Readers of this article also read:

A regenerative label-free fiber optic sensor using surface plasmon resonance for clinical diagnosis of fibrinogen

Nguyen TT, Bea SO, Kim DM, Yoon WJ, Park J-W, An SSA, Ju H

International Journal of Nanomedicine 2015, 10:155-163

Published Date: 27 August 2015

Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients

Li X, Wang T, Yang T, Shen Y, An J, Liu L, Dong J, Guo L, Li D, Zhang X, Chen L, Xu D, Wen F

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:587-594

Published Date: 17 March 2015

Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood–brain barrier in rats

Valiante S, Falanga A, Cigliano L, Iachetta G, Busiello RA, La Marca V, Galdiero M, Lombardi A, Galdiero S

International Journal of Nanomedicine 2015, 10:1885-1898

Published Date: 10 March 2015

Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea

Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:497-506

Published Date: 5 March 2015

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M

Patient Preference and Adherence 2014, 8:1713-1720

Published Date: 12 December 2014

Central airways remodeling in COPD patients

Pini L, Pinelli V, Modina D, Bezzi M, Tiberio L, Tantucci C

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:927-933

Published Date: 1 September 2014

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010